i2i Logic Partners with Wells Fargo to Provide Personalized Digital Services for Commercial Banking Clients
NEW YORK--(BUSINESS WIRE)--Today, i2i Logic and Wells Fargo & Company (NYSE:WFC) announced that the i2i Logic Client Intelligence Platform will be implemented by Wells Fargo Commercial Banking to drive a personalized experience for its clients.
"The right combination of tech, data, analytics and insight can transform the client service model in commercial banking."
Wells Fargo Benchmark Intelligence ©, driven by i2i Logic, integrates Wells Fargo's industry insights and U.S. middle-market expertise with public data to generate thousands of unique benchmarks. Sharing these data benchmarks with clients provides a highly personalized digital service – helping to assess and uncover their banking needs to offer the right financial solutions, such as cash management, working capital, long-term capital, and market risk products.
'Wells Fargo has data that, when utilized with the right digital solutions, makes it possible to gather insights that help clients understand the banking solutions they need to grow at scale,' said Kiran Vuppu, Head of Client Insights and Commercial Lending Product Management for Wells Fargo Commercial Banking. 'Not only can our commercial clients benefit from these tools, but they also create additional efficiencies for our bankers in speaking with clients.'
Tim Maddock, Co-Founder and Managing Director of i2i Logic noted 'the right combination of tech, data, analytics and insight can transform the client service model in commercial banking, and we are incredibly excited to collaborate with Wells Fargo and their bankers on their journey.'
About i2i Logic
The i2i Logic Client Intelligence Platform is used by commercial and corporate banks to generate intelligence on client needs – it links those needs to bank solutions in a beautiful workflow for the banker and provides supporting material in seconds. Bankers can see more clients more often; clients receive hyper personalized attention. i2i Logic has established offices in Melbourne, New York and London - servicing clients across all those time zones.
Contact i2i Logic at info@i2ilogic.com
Additional information may be found at www.i2ilogic.com
LinkedIn: https://www.linkedin.com/company/i2ilogic
About Wells Fargo
Wells Fargo & Company (NYSE: WFC) is a leading financial services company that has approximately $1.9 trillion in assets. We provide a diversified set of banking, investment and mortgage products and services, as well as consumer and commercial finance, through our four reportable operating segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. Wells Fargo ranked No. 34 on Fortune's 2024 rankings of America's largest corporations. News, insights, and perspectives from Wells Fargo are also available at Wells Fargo Stories.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Is the stock market open on Juneteenth 2025?
What we call the stock market in the United States is actually two different stock exchanges: the New York Stock Exchange (NYSE) and the Nasdaq. Luckily for American investors, both exchanges keep the same hours and observe the same holidays and half days. Typically, the stock market is open for trading every Monday through Friday from 9:30 a.m. to 4:00 p.m. ET, although it closes in observance of 10 different stock market holidays each year. The stock market will be closed on Thursday, June 19th, 2025, in observance of Juneteenth, which was recognized as a federal holiday in 2021. This means that investors should plan to execute any important trades before the 4:00 p.m. closing bell on Wednesday, Jun 18, or plan to delay them until after the 9:30 a.m. opening bell on Friday, June 20. Related: Juneteenth: What's open & what's closed on America's newest federal holiday That being said, many brokerages allow for extended-hours trading, meaning some investors may be able to make trades until 8:00 p.m. on Wednesday the 18th, or begin trading again starting at 4:00 a.m. on Friday the 18th. Here's a full list of all of 2025's stock market half days and holidays: The bond market, like the stock market, is closed on Monday, June 19, 2025, in observance of Juneteenth. Crypto assets like Bitcoin and Solana trade 24 hours a day, 7 days a week, so investors will be able to buy and sell cryptocurrencies on the 19th without interruption, even though it is a stock market holiday. Related: The best free trading apps for retail investors (& what they offer) The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
Business Wire
2 hours ago
- Business Wire
VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc.
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ('KSF') are investigating the proposed sale of Verve Therapeutics, Inc. (NasdaqGS: VERV) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of Verve will receive $10.50 per share in cash, plus one non-tradeable contingent value right per share entitling the holder to receive up to an additional $3.00 per share upon the achievement of certain milestones. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company. If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn ( toll free at any time at 855-768-1857, or visit to learn more. Please note that the transaction is structured as a tender offer, such that time may be of the essence. To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit
Business Upturn
3 hours ago
- Business Upturn
Kane Biotech Provides Further Corporate Update
WINNIPEG, Manitoba, June 18, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (the 'Company', 'Kane' or 'Kane Biotech') provides updates on its reorganizational phase. The Company has terminated its exclusive distribution agreement with ProgenaCare Global LLC ('ProgenaCare') dated April 18, 2023 due to various material breaches by ProgenaCare of the agreement. Activities to resecure distribution for its products in the United States are underway. The Company recently received a notice of default from Prairies Economic Development Canada ('PrairiesCan'). The notice relates to the Contribution Agreement between Western Economic Diversification Canada (now PrairiesCan) and Kane Biotech dated August 6, 2019, in which PrairiesCan provided the Company with repayable contributions of $2,491,266. The contributions are repayable in 59 consecutive monthly installments of $42,000 and one final instalment of $13,266 on an unsecured, interest-free basis which commenced on April 1, 2023. Kane has made all required repayments from April 1, 2023 to date excepting that of the payment due June 1, 2025. The Company has been in communication with PrairiesCan prior to the notice whereby it requested a restructuring of the timing of the remaining loan repayments with the intention of repaying the outstanding balance in full. Kane previously advised on April 28, 2025, that an unsecured demand loan of $1 million (the 'Loan') from an insider of the Company was entered into and funds received. The lender has agreed to convert the Loan to a five-year, unsecured convertible debenture in the principal amount of $1 million (the 'Debenture') all of which is subject to the approval of the TSX Venture Exchange. Interest on the Debenture shall accrue at the rate of three percent (3%) per annum, compounded annually and payable at maturity. The Debenture is convertible into common shares of Kane at the option of the holder at a price of $0.10 per common share. There are no broker fees or commissions related to this matter. The conversion of the Loan to the Debenture is a 'related party transaction' as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ('MI 61-101'). The Company is exempt from the formal valuation and minority approval requirements for related party transactions pursuant to Subsection 5.5(b) and Subsection 5.7(1)(e) of MI 61-101, respectively. The Company is now executing its clinical plan to underpin the commercial introduction of its revyveTM Antimicrobial Wound Gel and revyveTM Antimicrobial Wound Gel Spray in the US market. We are presently conducting clinical case series there with respected medical professionals in both chronic wound care and burn care patients which will result in the presentation of preclinical and clinical case series data in late 2025 and 2026. This press release does not constitute an offer to sell or the solicitation of an offer to buy this security, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful. The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or any state securities laws, and may not be offered or sold in the United States or to U.S. persons unless registered or exempt therefrom. About Kane Biotech Kane Biotech is developing novel wound care treatments that disrupt biofilms and transform healing outcomes. Biofilms are one of the main contributors to antibiotic resistance in wounds which results in serious clinical outcomes and significant cost. revyve™ addresses both biofilms and wound bacteria. For more information: Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Caution Regarding Forward-Looking Information This press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management's current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company's: (a) financial condition, including lack of significant revenues to date and reliance on equity and other financing; (b) business, including its early stage of development, government regulation, market acceptance for its products, rapid technological change and dependence on key personnel; (c) intellectual property including the ability of the Company to protect its intellectual property and dependence on its strategic partners; and (d) capital structure, including its lack of dividends on its common shares, volatility of the market price of its common shares and public company costs. Further information about these and other risks and uncertainties can be found in the disclosure documents filed by the Company with applicable securities regulatory authorities, available at The Company cautions that the foregoing list of factors that may affect future results is not exhaustive. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
